KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Cash from Investing Activities (2016 - 2025)

Novavax (NVAX) has 16 years of Cash from Investing Activities data on record, last reported at $20.5 million in Q4 2025.

  • For Q4 2025, Cash from Investing Activities fell 85.78% year-over-year to $20.5 million; the TTM value through Dec 2025 reached -$78.3 million, up 61.64%, while the annual FY2025 figure was -$78.3 million, 61.64% up from the prior year.
  • Cash from Investing Activities reached $20.5 million in Q4 2025 per NVAX's latest filing, up from -$136.5 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $144.0 million in Q4 2024 and bottomed at -$372.7 million in Q2 2024.
  • Average Cash from Investing Activities over 5 years is -$16.7 million, with a median of -$14.6 million recorded in 2021.
  • The widest YoY moves for Cash from Investing Activities: up 1686.33% in 2024, down 4691.19% in 2024.
  • A 5-year view of Cash from Investing Activities shows it stood at -$16.4 million in 2021, then tumbled by 34.83% to -$22.1 million in 2022, then surged by 58.86% to -$9.1 million in 2023, then soared by 1686.33% to $144.0 million in 2024, then tumbled by 85.78% to $20.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Investing Activities were $20.5 million in Q4 2025, -$136.5 million in Q3 2025, and $111.1 million in Q2 2025.